跳至主要内容
临床试验/IRCT2015063022991N1
IRCT2015063022991N1已完成未知

Comparing the efficacy of group-psychotherapy on breast cancer patients with major depressive disorder who are receiving citalopram

Babol University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
Female

入选标准

  • Breast cancer in the stage III or more; HADS score equals or more than 11 which can be due to symptomatic major depression; informed consent of the patient for participation in the study
  • Exclusion criteria: severe psychiatric disorders such as psychosis or substance abuse; severe neurologic diseases; mental retardation; endocrine disorders

排除标准

  • 未提供

研究者

相似试验